Keywords: elan, completes, sales, myobloc, solstice, neurosciences, irish

Elan completes sales of Myobloc to Solstice Neurosciences

Article | 12 July 2004

Print This

Irish drugmaker Elan Corp has completed the sale of its worldwiderights to Myobloc/Neurobloc (botulinum toxin type B) injectable solution, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in